News & Updates

Wendong Chen

TKI treatment failure is driving up the disease burden of CML

Normin Health just published a study leveraging the existing literature evidence addressing the disease burden of Chinese patients with...

Wendong Chen

Reducing uncertainty of economic evaluation using real-world data.

It is even more challenging to navigate in the mess of real-world data for the economic values of medical devices. We believe that our...

Wendong Chen

Case study for medical devices assessment in real-world setting

Normin Health just published a retrospective cohort study assessing powered stapler in video-assisted thoracic surgery (VATS) lobectomy...

Wendong Chen

Reimbursing infliximab for Crohn's disease is cost-effective in Chinese patients.

One of the collaboration projects of Normin Health has been published in Advances in Therapy. This project leveraged the real-world data...

Wendong Chen

Dr. Wendong Chen receives specially-appointed professor from Central South University in China

Dr. Wendong Chen has received the specially appointed professor from the Second Xiangya Hospital of Central South University in Changsha,...

Wendong Chen

Cost-Effectiveness of lenalidomide is attractive in Chinese patients with newly diagnosed MM

“The approval of lenalidomide for newly diagnosed multiple myeloma (MM) is expected to further improve the prognosis of multiple myeloma...

Wendong Chen

Flowable gelatin hemostatic matrix gains more clinical benefits in lumbar surgeries

Flowable gelatin hemostatic matrix was found to reduce blood transfusion without increasing hospital costs in real-world lumbar surgeries...

Wendong Chen

Dr. Wendong Chen gave a talk on real-world studies at THETA round

Dr. Chen shared the experiences of Normin Health in real-world evidence generation in China China has been becoming a health technology...